Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TELADOC HEALTH, INC.

(TDOC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/20/2022 01/21/2022 01/24/2022 01/25/2022 01/26/2022 Date
76.19(c) 72.9(c) 75.16(c) 72.03(c) 72.15 Last
4 987 047 5 521 467 6 924 670 3 914 084 2 651 333 Volume
+0.90% -4.32% +3.10% -4.16% +0.17% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 025 M - -
Net income 2021 -497 M - -
Net Debt 2021 343 M - -
P/E ratio 2021 -22,0x
Yield 2021 -
Sales 2022 2 575 M - -
Net income 2022 -285 M - -
Net Debt 2022 238 M - -
P/E ratio 2022 -40,0x
Yield 2022 -
Capitalization 11 531 M 11 531 M -
EV / Sales 2021 5,86x
EV / Sales 2022 4,57x
Nbr of Employees 4 026
Free-Float 94,3%
More Financials
Company
Teladoc Health, Inc. provides virtual healthcare services. The Company provides virtual access to care with a portfolio of services and solutions, which includes various medical subspecialties from non-urgent, episodic needs, such as flu and upper respiratory infections, to chronic, complicated medical conditions, such as hypertension, cancer and congestive heart failure. It provides provide virtual healthcare... 
More about the company
Ratings of Teladoc Health, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about TELADOC HEALTH, INC.
01/25Deutsche Bank Adjusts Teladoc's Price Target to $81 From $163, Maintains Hold Rating
MT
01/19Oppenheimer Adjusts Teladoc's Price Target to $160 From $185, Maintains Outperform Rati..
MT
01/19Berenberg Bank Assumes Coverage on Teladoc With Buy Rating, $141 Price Target
MT
01/18Barclays Adjusts Teladoc's Price Target to $95 From $150, Maintains Equalweight Rating
MT
01/11TRACKINSIGHT : 3 Thematic ETFs with early 2022 allure
TI
01/11Piper Sandler Adjusts Teladoc's Price Target to $118 From $183, Reiterates Overweight R..
MT
01/10TELADOC HEALTH : Investor Presentation - January 2022
PU
01/10TELADOC HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/10Teladoc Health, Inc. Provides Revenue Guidance for the Year Ending December 31, 2021
CI
01/07Credit Suisse Lowers Teladoc's PT to $151 from $207, Says Investors Concerned with Lack..
MT
01/05Teladoc Health to Participate in J.P. Morgan Healthcare Conference
AQ
2021Teladoc Shares Climb Amid Reports Cathie Wood's ARK Bought Millions of Dollars in Share..
MT
2021Teladoc HealtháImprovesáAccess to Whole-Person Care Through an Expanded Partnership wit..
GL
2021Teladoc HealtháImprovesáAccess to Whole-Person Care Through an Expanded Partnership wit..
GL
2021Teladoc Health Improves Access to Whole-Person Care Through an Expanded Partnership wit..
CI
More news
News in other languages on TELADOC HEALTH, INC.
01/11TRACKINSIGHT : á3 ETF thématiques attrayants en ce début 2022
01/10Teladoc Health, Inc. fournit des prévisions de revenus pour l'année se terminant le 31 ..
2021Les actions de Teladoc chutent après la rétrogradation de BTIG et les baisses de prix d..
2021Teladoc présente ses prévisions de revenus pour l'exercice 2022 et ses objectifs de cro..
2021Les actions du secteur de la santé en hausse jeudi dans le pré-marché
More news
Analyst Recommendations on TELADOC HEALTH, INC.
More recommendations
Chart TELADOC HEALTH, INC.
Duration : Period :
Teladoc Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELADOC HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 72,03 $
Average target price 144,28 $
Spread / Average Target 100%
EPS Revisions
Managers and Directors
Jason N. Gorevic Chief Executive Officer & Director
Mala Murthy Chief Financial Officer
David B. Snow Non-Executive Chairman
Jeff Nadler Chief Information Officer
Lewis Levy Chief Medical Officer
Sector and Competitors